MedTrace Logo

Transitioning Open Heart Surgery Patients From Insulin Infusions to Detemir

NCT00717288 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2011-10-03

Study results available
· View outcomes & findings →

Summary

In this study we will determine the proper method for transitioning patients from a continuous insulin infusion to periodic injections of a newer long-acting insulin called detemir (Levemir).

Conditions

Interventions

DRUG

Detemir

Detemir dosed at 50% of calculated basal insulin infusion requirements

DRUG

Detemir

Detemir dosed at 65% of calculated basal insulin infusion requirements

DRUG

Detemir

Detemir dosed at 80% of calculated basal insulin infusion requirements

Sponsors & Collaborators

Principal Investigators

  • Kathleen M Dungan, MD · Ohio State University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2010-03-31
Completion
2010-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00717288 on ClinicalTrials.gov